PCSA: Processa Pharmaceuticals, Inc. Stock

by  •  • Comments Off on PCSA: Processa Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.94
Enterprise Value ($M) 2.23
Book Value ($M) 4.99
Book Value / Share 1.75
Price / Book 1.39
NCAV ($M) 4.84
NCAV / Share 1.69
Price / NCAV 1.44

Profitability (mra)
Return on Invested Capital (ROIC) -2.16
Return on Assets (ROA) -0.89
Return on Equity (ROE) -1.10

Liquidity (mrq)
Quick Ratio 7.71
Current Ratio 7.71

Balance Sheet (mrq) ($M)
Current Assets 5.63
Assets 5.79
Liabilities 0.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -11.46
Net Income -11.12
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Warrants n/a
Earnings Per Share Common Shares Issued And Outstanding Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Common Shares Issued And Outstanding Basic n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -8.06
Cash from Investing -0.00
Cash from Financing 6.27

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 406,817 281,955 144.28
2024-04-25 24,557,056 6,872,030 357.35
2024-04-24 15,575 6,043 257.74
2024-04-23 10,239 1,150 890.35

(click for more detail)

Similar Companies
ORMP – Oramed Pharmaceuticals Inc. OTLK – Outlook Therapeutics, Inc.
PALI – Palisade Bio, Inc. PDSB – PDS Biotechnology Corporation
PHIO – Phio Pharmaceuticals Corp.


Financial data and stock pages provided by
Fintel.io